BEZAFIBRATE-INDUCED MYOLYSIS AND MYOGLOBINURIA IN PATIENTS WITH IMPAIRED RENAL-FUNCTION

被引:24
作者
RUMPF, KW
BARTH, M
BLECH, M
KAISER, H
KOOP, I
ARNOLD, R
SCHELER, F
机构
[1] UNIV GOTTINGEN,UROL KLIN,D-3400 GOTTINGEN,FED REP GER
[2] UNIV MARBURG KLINIKUMS,ZENTRUM INNERE MED,MARBURG,FED REP GER
来源
KLINISCHE WOCHENSCHRIFT | 1984年 / 62卷 / 08期
关键词
D O I
10.1007/BF01716252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:346 / 348
页数:3
相关论文
共 12 条
[1]   PHARMACOKINETICS OF BEZAFIBRATE AFTER SINGLE AND MULTIPLE DOSES IN THE PRESENCE OF RENAL-FAILURE [J].
ABSHAGEN, U ;
KOSTERS, W ;
KAUFMANN, B ;
LANG, PD .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (17) :889-896
[2]  
BRIDGMAN JF, 1972, LANCET, V2, P506
[3]  
DENIZOT M, 1973, LANCET, V1, P1326
[4]  
DOSA S, 1976, LANCET, V1, P250
[5]  
GIRAUD P, 1982, REV RHUM, V49, P162
[6]  
HEIDEMANN H, 1981, KLIN WOCHENSCHR, V59, P413
[7]   RADIOIMMUNOASSAY FOR HUMAN MYOGLOBIN - METHODOLOGY AND DIAGNOSTIC-SIGNIFICANCE IN MYOCARDIAL-INFARCTION [J].
KAISER, H ;
SPAAR, U ;
SOLD, G ;
WOLFRUM, DI ;
KREUZER, H .
KLINISCHE WOCHENSCHRIFT, 1979, 57 (05) :225-235
[8]   ACUTE MUSCULAR SYNDROME ASSOCIATED WITH ADMINISTRATION OF CLOFIBRATE [J].
LANGER, T ;
LEVY, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (16) :856-&
[9]  
MUNK ZM, 1977, CAN MED ASSOC J, V117, P1050
[10]  
PIERIDES AM, 1975, LANCET, V2, P1279